Panos Zanos

Citat de

	Toate	Din 2020
Referințe bibliografice	6828	5124
h-index	34	26
i10-index	56	54

1200

600

300

900

2015201620172018201920202021202220232024202534 127 304 468 657 845 939 994 1023 1142 180

Acces public

Afișați-le pe toate

50 de articole

2 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Todd D. GouldUniversity of Maryland School of MedicineAdresă de e-mail confirmată pe som.umaryland.edu
Polymnia GeorgiouAssistant ProfessorAdresă de e-mail confirmată pe uwm.edu
Carlos ZarateNational Institute of Mental HealthAdresă de e-mail confirmată pe mail.nih.gov
Patrick J. MorrisNational Center for Advancing Translational SciencesAdresă de e-mail confirmată pe nih.gov
Alexis BaileySt George's University of LondonAdresă de e-mail confirmată pe sgul.ac.uk
Scott ThompsonUniversity of Colorado School of MedicineAdresă de e-mail confirmată pe cuanschutz.edu
Ian KitchenProfessor of Neuropharmacology, University of SurreyAdresă de e-mail confirmată pe surrey.ac.uk
Edna PereiraUniversity of Maryland School of MedicineAdresă de e-mail confirmată pe som.umaryland.edu
Jaclyn HighlandUniversity of Maryland BaltimoreAdresă de e-mail confirmată pe umaryland.edu
XP HuangUniversity of North CarolinaAdresă de e-mail confirmată pe unc.edu
Heather J PributGraduate Student, University of Maryland College ParkAdresă de e-mail confirmată pe terpmail.umd.edu
Nagendra SinghCatalent Pharma Solution and National Institute of Aging/National InstituteAdresă de e-mail confirmată pe nih.gov
Lace M. RiggsMassachusetts Institute of TechnologyAdresă de e-mail confirmată pe mit.edu
Anna OnisiforouPostdoctoral Fellow, University of CypursAdresă de e-mail confirmată pe ucy.ac.cy
Adem CanAdresă de e-mail confirmată pe mail.mil
Ronald S DumanYale UniversityAdresă de e-mail confirmată pe yale.edu
Sarah M. ClarkAssistant Professor, University of Maryland School of MedicineAdresă de e-mail confirmată pe som.umaryland.edu
Margaret McCarthyChair and Professor, University of Maryland, BaltimoreAdresă de e-mail confirmată pe umaryland.edu
Istvan MerchenthalerProfessorAdresă de e-mail confirmată pe som.umaryland.edu
Rosana CamariniUniversidade de São PauloAdresă de e-mail confirmată pe icb.usp.br

Urmăriți

Panos Zanos

Assistant Professor of Neuropharmacology, University of Cyprus

Adresă de e-mail confirmată pe ucy.ac.cy - Pagina de pornire

Neuropharmacology Substance Use Disorders Depression Drug Repurposing Bioinformatics


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
NMDAR inhibition-independent antidepressant actions of ketamine metabolites P Zanos, R Moaddel, PJ Morris, P Georgiou, J Fischell, GI Elmer, ... Nature 533 (7604), 481-486, 2016	1611	2016
Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms P Zanos, R Moaddel, PJ Morris, LM Riggs, JN Highland, P Georgiou, ... Pharmacological reviews 70 (3), 621-660, 2018	1174	2018
Mechanisms of ketamine action as an antidepressant P Zanos, TD Gould Molecular psychiatry 23 (4), 801-811, 2018	1047	2018
Convergent mechanisms underlying rapid antidepressant action P Zanos, SM Thompson, RS Duman, CA Zarate, TD Gould CNS drugs 32, 197-227, 2018	180	2018
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function EW Lumsden, TA Troppoli, SJ Myers, P Zanos, Y Aracava, J Kehr, J Lovett, ... Proceedings of the National Academy of Sciences 116 (11), 5160-5169, 2019	167	2019
(2R,6R)-hydroxynorketamine exerts mGlu₂ receptor-dependent antidepressant actions P Zanos, JN Highland, BW Stewart, P Georgiou, CE Jenne, J Lovett, ... Proceedings of the National Academy of Sciences 116 (13), 6441-6450, 2019	150	2019
The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice P Zanos, P Georgiou, SR Wright, SM Hourani, I Kitchen, ... Neuropsychopharmacology 39 (4), 855-865, 2014	145	2014
Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters A Can, P Zanos, R Moaddel, HJ Kang, KSS Dossou, IW Wainer, JF Cheer, ... The Journal of Pharmacology and Experimental Therapeutics 359 (1), 159-170, 2016	128	2016
The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA/glycineB-site inhibition P Zanos, SC Piantadosi, HQ Wu, HJ Pribut, MJ Dell, A Can, ... The Journal of pharmacology and experimental therapeutics 355 (1), 76-85, 2015	114	2015
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor P Georgiou, P Zanos, TCM Mou, X An, DM Gerhard, DI Dryanovski, ... Nature neuroscience 25 (9), 1191-1200, 2022	111	2022
A negative allosteric modulator for alpha5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA … P Zanos, ME Nelson, JN Highland, SR Krimmel, P Georgiou, TD Gould, ... eneuro, 2017	106	2017
Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites PJ Morris, R Moaddel, P Zanos, CE Moore, T Gould, CA Zarate Jr, ... Organic letters 19 (17), 4572-4575, 2017	100	2017
Animal models to improve our understanding and treatment of suicidal behavior TD Gould, P Georgiou, LA Brenner, L Brundin, A Can, P Courtet, ... Translational psychiatry 7 (4), e1092-e1092, 2017	96	2017
(R)‐Ketamine exerts antidepressant actions partly via conversion to (2R,6R)‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses P Zanos, JN Highland, X Liu, TA Troppoli, P Georgiou, J Lovett, PJ Morris, ... British journal of pharmacology 176 (14), 2573-2592, 2019	83	2019
Hydroxynorketamines: pharmacology and potential therapeutic applications JN Highland, P Zanos, LM Riggs, P Georgiou, SM Clark, PJ Morris, ... Pharmacological reviews 73 (2), 763-791, 2021	80	2021
Dopamine and stress system modulation of sex differences in decision making P Georgiou, P Zanos, S Bhat, JK Tracy, IJ Merchenthaler, MM McCarthy, ... Neuropsychopharmacology 43 (2), 313-324, 2018	79	2018
Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent mechanism P Zanos, SR Wright, P Georgiou, JH Yoo, C Ledent, SM Hourani, I Kitchen, ... Pharmacology Biochemistry and Behavior 119, 72-79, 2014	66	2014
Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine JN Highland, PJ Morris, P Zanos, J Lovett, S Ghosh, AQ Wang, ... Journal of Psychopharmacology 33 (1), 12-24, 2019	63	2019
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression LT Park, B Kadriu, TD Gould, P Zanos, D Greenstein, JW Evans, P Yuan, ... International Journal of Neuropsychopharmacology 23 (7), 417-425, 2020	58	2020
Group II metabotropic glutamate receptor blockade promotes stress resilience in mice JN Highland, P Zanos, P Georgiou, TD Gould Neuropsychopharmacology 44 (10), 1788-1796, 2019	58	2019

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori